ECTRIMS 2022: Remyelination Research Insights - Dr Travis Stiles & A/Prof Alban Gaultier

Подписаться 3,7 тыс.

Просмотров 1,4 тыс.

50% 1

In this MStranslate exclusive, Dr Travis Stiles (CEO, Novoron Bioscience) sits down with A/Prof Alban Gaultier (Neuroscientist, University of Virginia) to discuss the latest developments in remyelination research and the future direction of the field. This discussion was filmed at the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held in Amsterdam, The Netherlands, between October 26 and 28, 2022.
Learn more about Novoron Bioscience: novoron.com
Learn more about The Gaultier Lab: www.gaultierlab.com
Learn more about ECTRIMS 2022: 2022.ectrims-congress.eu
Learn more about MStranslate and follow us on our other platforms via the links below:
Website: mstranslate.com.au
Facebook: / mstranslate
Twitter: / mstranslate
Instagram: / mstranslate
LinkedIn: / mstranslate

Наука

Опубликовано:

24 июл 2024

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист

Посмотреть позже

Комментарии : 11

@samanthafoor1594 Год назад

That was the most interesting to date! Thank you

@MStranslate1 Год назад

Thanks for the feedback Samantha - we're glad you enjoyed it!

@jodeep8695 Год назад

So there is hope, and hope is all we need. Things take time so I hope remy happens in the future not just for me but mostly for my son. So in his lifetime I have hope. Thanks heaps.

@jodeep8695 Год назад

Brett what would be the best organisation to fund raise for to assist research and work like this? I am keen to help fund a “hold up the fragile cells” work.

@jodeep8695 Год назад

Brett what would be the best organisation to fund raise for to assist research and work like this? I am keen to help fund a “hold up the fragile cells” work.

@flyingcloudsflyingcircus4694 Год назад

what do you think of FDA clemastine approved for remylination?

@quantumdecoherence1289 Год назад

Interesting conversation but I'm not sure remyelination will help axons that have already degenerated/died. Probably a good strategy for RRMS but likely of limited effect for chronic progressive MS.

@MStranslate1 Год назад

Yes, it may be that different strategies are required for this, which Travis and Alban touched upon. Another challenge, but it's good to see that ideas and progress are being made - even if they aren't necessarily always as quick as we'd hope for!

@ramazan9857 Год назад

they also said that they extend the myelin repair, which is the most important thing for MS patients, over the long term. Still waiting when people with ms don't have a day to wait. BORING!

@jodeep8695 Год назад

Brett what would be the best organisation to fund raise for to assist research and work like this? I am keen to help fund a “hold up the fragile cells” work.

@jodeep8695 Год назад

Brett what would be the best organisation to fund raise for to assist research and work like this? I am keen to help fund a “hold up the fragile cells” work.